Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance00:56

One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance

153
Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
153
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution01:09

One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution

541
The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated...
541
Two-Compartment Open Model: IV Bolus Administration01:18

Two-Compartment Open Model: IV Bolus Administration

733
The two-compartment model for intravenous (IV) bolus administration illustrates drug distribution in the body, subdividing it into central and peripheral compartments. This model operates on the concept of two-compartment kinetics. The drug's plasma concentration shows a bi-exponential decline following IV bolus administration, signaling the presence of two disposition processes: distribution and elimination.
The disparity between drug input and the sum of drug transfer rates between...
733
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

158
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
158
One-Compartment Open Model for IV Bolus Administration: General Considerations01:19

One-Compartment Open Model for IV Bolus Administration: General Considerations

349
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
349
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

232
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
232

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Estimating Population Immunity and Impact of COVID-19 Vaccination in Washington State and Oregon.

Open forum infectious diseases·2025
Same author

Bias in the estimated reporting fraction due to vaccination in the time-series SIR model.

PloS one·2025
Same author

Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults.

Nature medicine·2025
Same author

Understanding the sources of efficacy dilution in a trial of a monthly dapivirine vaginal ring for HIV-1 prevention.

International journal of STD & AIDS·2024
Same author

Closing the Gap in Race-based Inequities for Seasonal Influenza Hospitalizations: A Modeling Study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2024
Same author

Covid19Vaxplorer: A free, online, user-friendly COVID-19 vaccine allocation comparison tool.

PLOS global public health·2024

Related Experiment Video

Updated: Sep 26, 2025

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.4K

Optimizing one-dose and two-dose cholera vaccine allocation in outbreak settings: A modeling study.

Tiffany Leung1, Julia Eaton2, Laura Matrajt1

  • 1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.

Plos Neglected Tropical Diseases
|April 20, 2022
PubMed
Summary

A single dose of oral cholera vaccine (OCV) is more effective than two doses for outbreak response when vaccine supply is limited. This strategy can avert more cholera cases and deaths, especially in the short term.

More Related Videos

Laboratory Techniques Used to Maintain and Differentiate Biotypes of Vibrio cholerae Clinical and Environmental Isolates
07:58

Laboratory Techniques Used to Maintain and Differentiate Biotypes of Vibrio cholerae Clinical and Environmental Isolates

Published on: May 30, 2017

11.2K
Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
12:53

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

1.9K

Related Experiment Videos

Last Updated: Sep 26, 2025

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.4K
Laboratory Techniques Used to Maintain and Differentiate Biotypes of Vibrio cholerae Clinical and Environmental Isolates
07:58

Laboratory Techniques Used to Maintain and Differentiate Biotypes of Vibrio cholerae Clinical and Environmental Isolates

Published on: May 30, 2017

11.2K
Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
12:53

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

1.9K

Area of Science:

  • Epidemiology
  • Mathematical Modeling
  • Public Health

Background:

  • A global stockpile of oral cholera vaccine (OCV) exists for outbreak response, but vaccine supply is limited.
  • OCVs are typically administered as two-dose regimens, but studies suggest a single dose may offer significant protection.
  • Limited vaccine availability necessitates optimizing vaccination strategies.

Purpose of the Study:

  • To determine the optimal vaccination strategy (one vs. two doses) to minimize cholera infections and deaths.
  • To evaluate these strategies across diverse settings with varying population dynamics and migration patterns.
  • To compare the effectiveness of single-dose versus two-dose strategies under limited vaccine supply.

Main Methods:

  • Utilized a mathematical model incorporating two age groups and optimization algorithms.
  • Simulated vaccination scenarios in three distinct settings: a refugee camp (Maela), a densely populated urban area (N'Djamena), and a region with complex transport networks (Haiti).
  • Assessed outcomes based on cumulative overall infections, symptomatic infections, and deaths.

Main Results:

  • Under limited vaccine supply, prioritizing a single dose for older individuals (over five years) is optimal for short-term impact, regardless of setting.
  • Administering a second dose becomes optimal for long-term protection as vaccine availability increases.
  • Single-dose strategies can avert 1.2 to 1.8 times more cases and deaths than two-dose strategies in outbreak settings with limited supply.
  • Optimal single-dose strategies can avert 30-90% of deaths and 36-92% of symptomatic infections within one year across studied settings.

Conclusions:

  • In outbreak scenarios with limited oral cholera vaccine (OCV) supply, rapid single-dose vaccination campaigns are more effective at averting cases and deaths than two-dose campaigns.
  • The findings support the use of single-dose OCV strategies for immediate outbreak control when resources are constrained.
  • Optimizing vaccine allocation through single-dose strategies can significantly enhance public health outcomes during cholera outbreaks.